SEC Company Response from BIO BRIDGE SCIENCE INC (CIK 0001309304) — Aug 12, 2005

BIO BRIDGE SCIENCE INC (CIK 0001309304)
Date: Aug. 12, 2005 · CIK: 0001309304 · Accession: 0001144204-05-025083

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-121786

Date

August 12, 2005

Author

Not clearly detected

Form

CORRESP

Company

BIO BRIDGE SCIENCE INC (CIK 0001309304)

Letter

Re: Bio-Bridge Science, Inc. Registration Statement on Form SB-2 File No. 333-121786

BIO-BRIDGE SCIENCE, INC. 1211 West 22nd Street, Suite 615 Oak Brook, IL 60523

August 12, 2005

VIA FACSIMILE AND EDGAR

Securities and Exchange Commission 450 Fifth Street, N. W. Washington, D. C. 20549

Ladies and Gentlemen:

Bio-Bridge Science, Inc. (the "Company") hereby requests that the Commission take appropriate action to cause the above-referenced registration statement on Form SB-2 to become effective on August 12, 2005 at 5:30 p.m. Washington, D.C. time.

The Company hereby acknowledges the following:

o should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

o the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

o the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very truly yours,
BIO-BRIDGE SCIENCE, INC.

Show Raw Text

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

                            BIO-BRIDGE SCIENCE, INC.
                        1211 West 22nd Street, Suite 615
                               Oak Brook, IL 60523

                                 August 12, 2005

VIA FACSIMILE AND EDGAR

Securities and Exchange Commission
450 Fifth Street, N. W.
Washington, D. C. 20549

            Re:        Bio-Bridge Science, Inc.
                       Registration Statement on Form SB-2
                       File No. 333-121786

Ladies and Gentlemen:

      Bio-Bridge Science, Inc. (the "Company") hereby requests that the
Commission take appropriate action to cause the above-referenced registration
statement on Form SB-2 to become effective on August 12, 2005 at 5:30 p.m.
Washington, D.C. time.

         The Company hereby acknowledges the following:

      o     should the Commission or the staff, acting pursuant to delegated
            authority, declare the filing effective, it does not foreclose the
            Commission from taking any action with respect to the filing;

      o     the action of the Commission or the staff, acting pursuant to
            delegated authority, in declaring the filing effective, does not
            relieve the Company from its full responsibility for the adequacy
            and accuracy of the disclosure in the filing; and

      o     the Company may not assert staff comments and the declaration of
            effectiveness as a defense in any proceeding initiated by the
            Commission or any person under the federal securities laws of the
            United States.

                                            Very truly yours,

                                            BIO-BRIDGE SCIENCE, INC.

                                            By: /s/ Liang Qiao, M.D.
                                                -------------------------------
                                                     Liang Qiao, M.D.
                                                     Chief Executive Officer
</TEXT>
</DOCUMENT>

SecProbe.io